Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Aug 10;187(4):817–827. doi: 10.1093/aje/kwx287

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2018. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/about_us/legal/notices)

PMC Copyright notice

Figure 3. — Treatment effect (hazard ratio (HR) and 95% confidence interval (CI)) of rosuvastatin in the multiple-country trial, Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) (2003–2008), before and after standardizing to the complete case cohort and complete case cohort among patients aged <80 years without selection weight truncation. For the results from JUPITER standardized to the imputed cohort, the hazard ratios were first estimated in JUPITER standardized to each imputed data set (Web Table 9) and then combined into overall estimates to account for variability.